Gradual Shift toward hybrid and electric vehicles is expected to impact braking technology used in light-trucks and cars in the coming years. With upcoming trends including electrification, autonomous driving, new mobility and light weighting has influenced automotive brake components manufacturers to develop braking system compatible products in a bid to remain in alignment with the current novelties in braking technology. In addition, with the introduction of “Eddy Current Brakes”, the periodic changing of automotive brake components can be significantly reduced using the frictionless braking technology. This aspect has been deemed as a potential breakthrough among OEMs, which is expected to impact the growth of automotive brake components market in the coming years.

Report Summary of the Report: https://www.factmr.com/report/24/automotive-brake-component-market

Brake calipers in disc brake systems is expected to witness significant demand on the back of growing preference for aluminum automotive brake components. Moreover, the trend of anodizing brake calipers, particularly for use in high quality vehicles has been witnessed in the automotive brake components market. Additional treatment of anodizing the caliper surface ensures enhanced corrosion protection, improve wear resistance and appearance. Additionally, anodized brake calipers can be colored to increase the aesthetic quotient with paints that can further increase weather resistance.

Prevalence of counterfeit products in the automotive sector called for same regulations apropos to labelling standards of replacement automotive brake components as original brake components in a bid to ensure vehicle safety. This triggered the implementation of ECE R90 regulation that is applicable to vehicles sold across European Union along with 30 nations in Asia Pacific and Africa. ECE R90 has revised several mandates with regards to specific designs, performance and construction requirements for labelling for automotive brake components. The labelling initiative can ensure same performance within the tolerance limits of original vehicles. This initiative is likely to offset the impact of counterfeit products on the automotive brake components market, in turn auguring well for its overall growth.

Get the Sample PDF of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=24

Significant opportunities can be grabbed in the emerging economies of Asia Pacific on the back of growing domestic automotive sector coupled with increasing investments in research and development and massive technological shift. Automotive brake components manufacturers are planning to tap new vehicle segments in emerging economies of China and India along with introduction of advanced automotive brake components to gain high margins. Stakeholders are focusing on penetrating these emerging lands to capture major revenue funnels offered by business-environment friendly countries. Moreover, OEMs have considered Asia Pacific as a major sourcing hub not only for automotive brake components but also other auto components and consolidate their positions in emerging markets to leverage upcoming opportunities. Against this backdrop, Asia Pacific is likely remain a lucrative market for automotive brake components for its aftermarket. Moreover, auto components manufacturers are signing joint ventures to tap the Asian market for specific vehicle segments. For instance, ASK Automotive and Fras-le (Brazil) have set up a joint venture of linings and brake pads facility especially for commercial vehicles in Haryana with an investment of over US$ 15 million in 2018.

Automotive Brake Components Market Forecast, Trends Analysis and Competition Tracking – Global Review 2017-2022” offers unbiased intelligence on several aspects of the market. The demand and sales scenario of automotive brake components has been highlighted in the report. Moreover, analysis on various segments of the market including assessment on automotive brake components used in disc brakes such as rotors, calipers and brake pads and those used in drum brakes such as drums, brake shoes and wheel cylinder has been covered in the report. Moreover, analysis on brake booster and master cylinder is also included. The sales analysis of automotive brake components in passenger cars, in light commercial vehicles and heavy commercial vehicles in the aftermarket is also provided. All these segments are analyzed across major regions in the globe including North America, Latin America, Europe, Japan, Asia Pacific excluding Japan (APEJ) and Middle East and Africa (MEA) along with historical and current market data and forecasts for a period of 10 years.

Report Customization can be done at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=24

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593 
Email: sales@factmr.com
Blog: https://theheraldmedia.com/

According to Fact.MR’s new business intelligence report, the global automotive pumps market is anticipated to register a promising growth during the period 2017-2026, with market revenues likely to surpass US$ 54 billion by 2019-end. Growing consumer preference for green technology, along with the need to adhere to stringent carbon and VOC emission regulations, are encouraging automotive manufacturers to focus on enhancing energy performance of vehicles. With their crucial role in maintenance of energy efficiency, the automotive pumps are likely to gain center stage in the near future.

Report Summary of the Report: https://www.factmr.com/report/25/automotive-pump-market

Increasing demand for fuel-efficient and lightweight vehicles has been influencing leading automotive manufactures to implement innovative technologies in automobile components. Advances in technologies such as automatic transmission, gasoline direct injection, and gasoline turbocharger that enable efficient circulation of oil in all parts of an automobile are likely to create lucrative opportunities for manufacturers of automotive pumps.

Growing vehicle parc and the emergence of a large middle-class demographic with high disposable income are directly translating into the growth of automotive market in emerging economies and eventually complementing the expansion of automotive pumps market. In addition, high purchasing capabilities of consumers in these regions are prompting automakers to improve their production of mid-sized and compact cars. Moreover, introduction of premium aspects such as anti-lock brake system (ABS), power steering, easy gear shift, and cabin comfort system in these cars is likely to influence the need for custom-made automotive pumps which may open new avenues of market growth.

With escalating demand for high-performance vehicles on the account rising fuel prices, automotive manufactures are heavily investing in R&D to develop highly efficient transmission system and low-friction pumps which will possibly create potential growth prospects of automotive pumps market.

Get the Sample PDF of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=25

Electric automotive pumps are independent of combustion engines which help enhance fuel efficiency and significantly reduce the carbon emission of vehicles. This has led to adoption transition from mechanical automotive pumps to electric pumps. Expanding at an estimated CAGR of 5.5% over the forecast period, the sales of electric automotive pumps are projected to cross 590,000 units by 2026-end. Electric pumps are highly sought-after for their excellent performance standards and are predicted to contribute a slightly higher share than mechanical variants to the automotive pumps market by the end of the forecast period.

Booming automotive manufacturing industry in Asia Pacific Excluding Japan (APEJ) is expected to directly impact the growth of automotive pumps market in the region. APEJ is projected to reign supreme in the automotive pumps market in 2017, accounting for the largest revenue share, and the trend is expected to continue over the forecast period.

Ever-increasing population, mass urbanization, robust industrialization, and changing consumer behavior in emerging economies are the key factors driving APEJ automotive pumps market. APEJ is deemed to be the most attractive market of automotive pumps, expanding at a promising CAGR of 5.5% during the 2017-2026 period.

Report Customization can be done at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=25

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593 
Email: sales@factmr.com
Blog: https://theheraldmedia.com/

A syringe is a medical device used for injecting fluids into the body, or to withdraw fluid from the body. A typical medical syringe has a needle attached to a hollow cylinder, which is fitted with a sliding plunger. By pushing the plunger in downward movement, the fluids are injected in a body, and retracting the plunger in upward direction extracts fluids from the body.

Report Summary of the Report: https://www.factmr.com/report/59/syringes-market

Invasive nature of medical procedures might frighten patients at first, but injecting medications turns out to be the healthier option over tropical application or oral intake. Supporting this notion, syringes continue to be a key product in the healthcare industry, offering optimum drug administration with minimal discomfort. Concurring to such particulars, the Fact.MR report on global syringes market predicts that the global demand for syringes will continue to surge in the years to come.

According to the report, more than US$ 11 Bn worth of syringes will be sold in the world by the end of 2017. With increasing advancements in drug administration techniques, surgical industries will witness the emergence of new, multifunctional syringes, which will incidentally have a promising influence on the growth of global syringes market. Through 2022, the global market for syringes will have soared at 7.8% CAGR, procuring revenues worth more than US$ 16.5 Bn.

Easy usability of standard syringes have made them a household commodity as consumers are attaining proper training, and administrating common vaccines by themselves. Meanwhile, medical organizations are prompting surgeons & medical practitioners towards higher adoption of specialized syringes. Unlike standard syringes, their specialized counterparts are successfully lowering healthcare costs by performing multiple injection functions at the cost of a single syringe. While their influence in cutting the medical bills of patients is marginal, specialized syringes are certainly drawing more adoption for their effectiveness.

Get the Sample PDF of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=59

In 2017 and beyond, more than 30% of global syringes market will procure its value through global sales of specialized syringes. The report, however, doesn’t understate the dominance of general syringes in the global market. With the largest revenue share, general syringes are expected to contribute more than US$ 3.5 Bn revenues to the global market by the end of 2022.

The report has also profiled leading players in the global syringes market, which include companies such as B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG, Terumo Corporation, Hindustan Syringes & Medical Devices Limited, Nipro Corporation, Medtronic PLC, Schott AG, Codan Medizinische Geräte GmbH & Co Kg, and Schott AG.

Report Customization can be done at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=59

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593 
Email: sales@factmr.com
Blog: https://theheraldmedia.com/

Ultrasound systems are imaging devices that employ high-frequency sound waves for capturing live images from inside of the patient’s body. Ultrasound as a scanning method is often synonymous to sonography. Ultrasound systems are predominantly used in pregnancy diagnostics, but these systems can also procure accurate images in all other fields of diagnostics as well.

Report Summary of the Report: https://www.factmr.com/report/60/ultrasound-systems-market

Precise medical imaging has a controlling influence over the efficacy of subsequent procedures, which is why medical professionals continue to prefer accurate imaging methods such as ultrasound.

The Fact.MR report on global market for ultrasound systems accedes to this notion, projecting a steady growth in the global demand for ultrasound systems during 2017-2022. According to the report, the global ultrasound systems market will reach US$ 6 Bn value by the end of 2017. Ultrasound imaging systems will continue to gain ground due to their affordable costs and higher accuracy, particularly for diagnostic imaging during pregnancy. Towards the end of 2022, the global ultrasound systems market value is anticipated to soar steadily at 5.5% CAGR, bringing in revenues worth over US$ 7.8 Bn.

The report reveals that ultrasound systems are paramount in gynecological imaging, even so a major share of ultrasound systems sold globally are accounted by cardiology diagnostics. Rising incidence rate of myocardial infarction and angina in the world is making the use of ultrasound systems imperative in the field of cardiology. Between 2017 and 2022, the global sales of ultrasound systems in cardiology applications are expected to create an incremental opportunity of more than US$ 430 Mn.

Get the Sample PDF of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=60

Portability of ultrasound systems is becoming a governing factor for boosting its global sales. Preference to portable ultrasound systems will be distinctly high across all medical settings. During the forecast period, global revenues accounted by sales of portable ultrasound systems are anticipated to exhibit growth at a surging CAGR of 6.4%. While portable ultrasound systems will mark a little over 17% share on global revenues through 2022, the market will continue to witness foremost demand for standalone ultrasound systems. In 2017, the global market for ultrasound systems is pegged to rake in revenues worth over US$ 4.2 Bn, exclusively from the sales of standalone ultrasound systems.

Ultrasound is staple imaging technology in independent radiology centers as well as radiology departments in hospitals. With increasing demand for radiotherapy, the adoption of ultrasound systems is slated to rise across all general hospitals. The report observes hospitals as the largest end-user of ultrasound systems in the global market, projecting that this segment will account for approximately 50% of the global market revenues through 2022. Diagnostic centers are also expected to account for greater end-use of ultrasound systems in the global market. By the end of 2022, more than US$ 1.5 Bn worth of revenues will be reaped from global sales of ultrasound systems in diagnostic centers.

Report Customization can be done at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=60

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593 
Email: sales@factmr.com
Blog: https://theheraldmedia.com/

According to a recent Fact.MR study, the global US$ 75 billion OTC vitamins and dietary supplements market is likely to grow at 6.6% in 2019. Growing focus on preventive healthcare remains one of the key driving factors for OTC vitamins and dietary supplements market. The study opines that North America, led by steady sales in the US, will continue to retain its leading position in the OTC vitamins and dietary supplements market, accounting for relatively high revenue share in 2018. Proliferating health-conscious demographic and continuous introduction of new products by manufacturers in the OTC vitamins and dietary supplements industry are likely have a significant influence on the market performance in North America.

Report Summary of the Report: https://www.factmr.com/report/61/otc-vitamins-dietary-supplements-market

APEJ is anticipated to emerge as the most attractive region for OTC vitamins and dietary supplements market on the back high disposable income, influencing consumers to trade up to premium supplements and purchase a high-quality variety of goods. Growing awareness regarding the health benefits of these supplements along with their buying convenience and cost effectiveness is likely to favor the expansion of OTC vitamins and dietary supplements market in various countries across APEJ.

The study also finds that emerging trends of self-directed consumers and self-medication for addressing minor health issues will be highly impactful on the overall growth of global OTC vitamins and dietary supplements market.

Pharmacy is projected to be the leading OTC channel in global OTC vitamins and dietary supplements market, accounting for over 27% revenue share in 2017. However, the segment is foreseen to lose a small fraction of its share, due to penetration of new OTC channels including modern trade and online store.

Get the Sample PDF of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=61

In addition to adopting new channels to promote and sell their products, manufacturers in OTC vitamins and dietary supplements industry are focusing on improving the functionality of these supplements through innovations in product formulation. This, in turn, is expected to open new avenues of growth of OTC vitamins and dietary supplements market.

Significant growth of the OTC vitamins and dietary supplements market can be attributed to relatively high sales of capsule based products, which closed in a valuation of nearly US$ 23.6 billion in 2017.

Based on function, the use of OTC vitamins and dietary supplements is likely to remain robust for maintaining general well-being of the body. The segment is expected to represent a significant revenue share of more than 25% in the global OTC vitamins and dietary supplements market in 2017.

Report Customization can be done at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=61

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593 
Email: sales@factmr.com
Blog: https://theheraldmedia.com/

Colorectal cancer diagnostics are a wide range of screening tests and diagnosis procedures that are employed before treating a patient with colon cancer. A typical diagnosis of colorectal cancer consists of tests such as colonoscopy, biopsy, blood sample testing, CT scan, ultrasound, MRI and molecular testing of the growing tumor. 

Report Summary of the Report: https://www.factmr.com/report/70/colorectal-cancer-diagnostics-market

A recent report by Fact.MR projects the global colorectal cancer diagnostics market to register an impressive expansion at 8.5% CAGR during the forecast period 2017 to 2022. Revenues from the global colorectal cancer diagnostics market is expected to surpass US$ 2,000 Mn by 2022-end.

The emergence of new improved diagnosis tests, soaring uptakes of diagnosis-associated therapies, and increasing initiatives by private and government organisations are factors likely to fuel growth of the global colorectal cancer diagnostics market. Surging unmet requirements for colorectal cancer diagnostics around many emerging economies, along with the shortage of neoadjuvant as well as adjuvant pipeline agents for diagnosing high-risk patients suffering from resectable colorectal cancer is anticipated to pave tremendous growth opportunities for global leaders in the market. In contrast, factors such as rising patient reluctance against medications of colorectal cancer, and absence of awareness about therapeutics and diagnostics of colorectal cancer in many remote regions around the world is estimated to impede the market growth.

The World Cancer Research Fund estimates the colorectal cancer to be the third-most occurring form of cancer around the world. In 2012, more than 1 Mn people were diagnosed with colorectal cancer. Majority of these were reported in the developed economies, and this is anticipated to surge in the near future. These incidences of colorectal cancer have boosted demand for their diagnostics worldwide. In addition, the number of deaths caused by colorectal cancer has witnessed a decline over the recent past, on the back of awareness spread by American Cancer Society (ACS). Introduction of effective instruments, along with the development of screening methods are estimated to further propel growth of the global market for colorectal cancer diagnostics.

Get the Sample PDF of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=70

The market for colorectal cancer diagnostics in Asia Pacific excluding Japan (APEJ) is estimated to exhibit the fastest expansion throughout the forecast period. Revenue from the market in Middle East & Africa (MEA) will continue to be sluggish during the forecast period. North America will remain the most lucrative region for colorectal cancer diagnostics. North America’s colorectal cancer diagnostics market is anticipated to account for nearly US$ 800 Mn in revenues by 2022-end. Markets in Europe and North America are estimated to register a parallel expansion at a CAGR of 8.6% through 2022.

FOB tests will remain the largest adopted tests for colorectal cancer diagnostics across the globe. In addition, FOB tests in the global colorectal cancer diagnostics market will account for the largest revenues, followed by CTC tests. The immunochemistry tests will register the highest CAGR in the market through 2022. However, BRAF tests will account for the lowest revenues in the global market for colorectal cancer diagnostics throughout the forecast period.

Based on end-users, even though hospital-associated labs are estimated to remain sought-after for colorectal cancer diagnostics, cancer research institutes will register the fastest expansion through 2022. Hospital-associated labs in the global colorectal cancer diagnostics market are estimated to account for nearly US$ 1,000 Mn in revenues by 2022-end. In addition, independent diagnostic laboratories will remain the second largest end-users of colorectal cancer diagnostics in the global market.

Report Customization can be done at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=70

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593 
Email: sales@factmr.com
Blog: https://theheraldmedia.com/

Very few individuals consult doctors for common conditions such as cold, cough and allergies; most of them opt for OTC medicines instead.  In the view of such prominent practices, the global sales of the OTC cough, cold and allergy medicines have remained propped up for the past decade or so. Cough, cold and allergy medicines are one of most common OTC (over-the-counter) categories, however, physicians recommend their use only for minor health issues. In many countries, there are certain laws enforced on directs sales of these medicines in order to ensure consumer safety.  In addition, these medicines offer extreme convenience to a modern consumer, living a fast-paced life. The aforementioned factors are expected to reflect favorably on the global OTC cough, cold and allergy medicines market over the next five years. Moreover, an increasing number of immunosuppressed individuals and rising global geriatric population is also expected to further drive the demand OTC medicines for cough, cold and allergy.  The recent study conducted by Fact.MR reveals that the global OTC cough, cold and allergy medicine market is poised to increase at a CAGR of 4.9% during 2017 to 2022 to reach a valuation of around US$ 37,300 Mn.

Report Summary of the Report: https://www.factmr.com/report/71/otc-cough-cold-allergy-medicine-market

Asia-Pacific excluding Japan (APEJ) is projected to remain the most lucrative market for OTC cough, cold and allergy medicines throughout the forecast period. In terms of revenue, APEJ is anticipated to account for an impressive share of the global market in 2017 and beyond. The region’s proximity to air pollution has led to the rise in prevalence of various respiratory disorders. Moreover, acceptance rate of OTC medicines is extremely high in the region owing to their low cost and convenience of purchase.

By drug type, antihistamine is projected to account for more than one-third share of the market in terms of revenue by 2017-end. Antihistamines drugs reduce the release of histamine from histamine-1 receptors and are commonly used for treating allergic reactions such as inflammation (redness), swelling (edema), watery eyes or runny nose and sneezing.

Get the Sample PDF of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=71

Pharmacies will remain the leading OTC channel for sales of cough, cold and allergy medicines during the assessment period.  Meanwhile, drug store OTC channel segment is expected to account for the second largest revenue share of the market by 2017-end.

By dosage, the tablet segment is estimated to account for more than 33% revenue share of the market and is expected to reach a valuation of around US$ 12,400 Mn towards the end of the forecast period.

Key companies profiled in Fact.MR’s report include Sanofi-Aventis, Johnson & Johnson Service, Inc., Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZaneca Plc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Prestige Brands Holdings, Inc., Procter & Gamble Co., Bristol-Myers Squib Co., Merck & Co., and Allergen. Many of these market players are actively focusing on increasing their market presence and development of more efficient products.

Report Customization can be done at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=71

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593 
Email: sales@factmr.com
Blog: https://theheraldmedia.com/

Herbal medicines are naturally derived medicines for treatment of various ailments. These generally represent medicines sourced from medicinal herbs, or, plants. Traditional medicines are sum of practices, skills, and knowledge based on experiences, beliefs, and theories indigenous to various cultures, used for prevention, and maintenance of health. Various types of herbal and traditional medicines include Chinese/oriental medicines, naturopathy, homeopathy, and Ayurveda.

Report Summary of the Report: https://www.factmr.com/report/72/otc-herbal-and-traditional-medicines-market

According to a recent research by Fact.MR, the global OTC herbal and traditional medicines market is estimated to exhibit a moderate expansion at a CAGR of 4.8% during the forecast period 2017 to 2022. The global market for OTC herbal and traditional medicines will account for revenues over US$ 20,000 Mn in 2017. Revenues from the market are further estimated to exceed US$ 30,000 Mn by 2022-end.

Traditional and herbal systems of medicines have always played a crucial role in meeting the requirements of the global health care. According to the Ministry of AYUSH, India, a rising trend towards Ayurveda, Yoga, and Unani is being witnessed across the globe. Increasing concerns of consumers pertaining to the integrity of synthetic drugs has led them towards adoption of traditional and herbal medicines, creating huge opportunities for manufacturers. The consumer health sector has been witnessing transformations, where principles of traditional medicines are being rediscovered, and introduced to cater the rising consumer demand for natural prevention and treatment options. This in turn is expected to pave a new opportunity for manufacturers, who are facing problems pertaining to safety of synthetic OTC drugs. The aforementioned factors are projected to augment growth of the global OTC herbal and traditional medicines market.

Get the Sample PDF of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=72

Although traditional and herbal systems of medicines comprise of valuable elements, they also contain ingredients that are harmful and result into side-effects. Two aspects for their safety evaluation considered are no adulteration/contamination, and right quality of ingredients. This necessitates doctor’s prescription before use of traditional and herbal medicines, which may hinder growth of the market. A slew of well-maintained research centres such as India’s AYUSH, and Dabur Research & Development Center are focusing on R&D related to traditional and herbal medicines, especially Ayurvedic medicines. The transforming healthcare environment worldwide is in dire need for the comprehensive policy review of herbal and traditional systems of medicine.

Asia Pacific excluding Japan (APEJ) is anticipated to be dominant in the market in 2017, and the trend is expected to witness a steady growth through 2022. North America is estimated to be the second largest market for OTC herbal and traditional medicines by 2022-end. Japan will continue to be the least lucrative region in the global OTC herbal and traditional medicines market.

Based on function, sales of OTC herbal and traditional medicines in maintaining digestive health of people are expected to account for the largest revenues by 2022-end. Sales of OTC herbal and traditional medicines for nutrition, and bone & joint health are expected to exhibit a parallel expansion at similar CAGRs, however, revenues from sales for nutrition will remain comparatively higher than that from bone & joint health.

Report Customization can be done at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=72

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593 
Email: sales@factmr.com
Blog: https://theheraldmedia.com/

Traditionally recognized for a wealth of cardio-protective properties, Argan oil is extensively used in treating various skin infection conditions. Moreover, a recent research has found out that the application base of Argan oil is widening – associated with the basic cardio-protective peculiarities. Argan oil is also found to possess unique organoleptic attributes, enabling it to create a multimillion dollar international market in the edible oils sector. Escalating consumer awareness about including essential edible oils in their dietary routine is expected to create highly competitive opportunities for Argan oil producers and processors in the near future.

Report Overview: https://www.factmr.com/report/86/argan-oil-market

Sustainable tourism has been an effective source income for rural population over the decades. A number of active local cooperatives in the Argan oil production space that are based in the Middle East and North Africa have been lately gaining encouragement and strong support by BMZ (the German Federal Ministry for Economic Cooperation and Development) and GIZ (the Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH).

Both the authorities are promoting the initiative of sustainable tourism with an objective to uplift several women’s cooperatives that dedicatedly form a sizable workforce in traditionally significant Argan oil production practices. Furthermore, ecotourism – collectively with local tour operators and hotels – brings in exotic visitors who are ideal potential customers for traditionally significant practices such as Argan oil production. This and more such activities are expected to fuel the growth of Argan oil market in the near future.

High restorative qualities of Argan oil have been considered to be the primary factor pushing interests of cosmetic and anti-aging product manufacturers in Argan oil over the past decade. While Argan oil helps restore the elasticity, moisture, and nutrient content of facial as well as overall skin, it is most likely that the next few years will continue to witness surging traction for Argan oil in anti-aging products. Argan oil is also anticipated to experience elevating consumption in various topical pharmacological products, as it effectively addresses a wide array of skin health conditions. Exceptional advantages of using Argan oil for hair will continue to sustain the demand from the dermatological segment.

Get the Report Sample to gain more information on the competitive landscape: https://www.factmr.com/connectus/sample?flag=S&rep_id=86

High restorative qualities of Argan oil have been considered to be the primary factor pushing interests of cosmetic and anti-aging product manufacturers in Argan oil over the past decade. While Argan oil helps restore the elasticity, moisture, and nutrient content of facial as well as overall skin, it is most likely that the next few years will continue to witness surging traction for Argan oil in anti-aging products. Argan oil is also anticipated to experience elevating consumption in various topical pharmacological products, as it effectively addresses a wide array of skin health conditions. Exceptional advantages of using Argan oil for hair will continue to sustain the demand from the dermatological segment.

Financial support to Argan oil producing cooperatives has enabled several of them to implement the use of state-of-the-art machinery for various production steps – translating into improved product quality and quantity. In recent years, GIZ has sponsored equipment such as oil filters and pressed, roasting machines, and filling devices, in addition to providing financial aid for women’s professional training covering both business and technical aspects of a typical Argan oil production cooperative. Local companies are thus increasingly proposing and executing sophisticated marketing strategies to consistently push Argan oil sales, which offers an optimistic outlook to the Argan oil market scenario.

Report Customization can be done at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=86

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593 
Email: sales@factmr.com
Blog: https://theheraldmedia.com/